Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Cancer Research|September 2, 2022
Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic CancerJuho Pirhonen, Ábel Szkalisity, Jaana Hagström, et al.
Biomolecules|April 2, 2020
Identification and Validation of VEGFR2 Kinase as a Target of Voacangine by a Systematic Combination of DARTS and MSIYonghyo Kim, Yutaka Sugihara, Tae Young Kim, et al.
British Journal of Cancer|December 14, 2025
Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancerBüsra Ernhofer, Anna Solta, Julia Sinner, et al.
Plos One|April 16, 2015
A protein deep sequencing evaluation of metastatic melanoma tissuesCharlotte Welinder, Krzysztof Pawłowski, Yutaka Sugihara, et al.
Scientific Data|December 4, 2021
Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysisHazal Haytural, Rui Benfeitas, Sophia Schedin-Weiss, et al.
Cancer Metastasis Reviews|July 6, 2015
Erratum to: Association of chromosome 19 to lung cancer genotypes and phenotypesXiangdong Wang, Yong Zhang, Carol L Nilsson, et al.
Cancer Metastasis Reviews|May 19, 2015
Association of chromosome 19 to lung cancer genotypes and phenotypesXiangdong Wang, Yong Zhang, Carol L Nilsson, et al.
Theranostics|January 3, 2017
Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis InhibitorsSzilvia Torok, Melinda Rezeli, Olga Kelemen, et al.
Magyar Onkologia|October 5, 2021
[Heterogeneity of small cell lung cancer: biological and clinicopathological implications]Zsolt Megyesfalvi, Nándor Bárány, Zsuzsanna Valkó, et al.
Molecular Therapy Oncolytics|March 15, 2021
Molecular profiles of small cell lung cancer subtypes: therapeutic implicationsAnna Schwendenwein, Zsolt Megyesfalvi, Nandor Barany, et al.
Pageof 11